"In the meantime, for the forthcoming flu season, our priority remains to ensure a high uptakerate is achieved in the at risk groups including pregnant women, " he added.
Despite these positive attributes, we have modest expectations for Invokana and the SGLT-2 class because the drug and class are associated with a relatively high rate of genital infections which will limit uptake in our view.